- In February 2025, Siemens Healthineers launched the Atellica CH Analyzer in key European countries, offering enhanced automation and faster turnaround times for clinical chemistry and immunoassay testing, reflecting the growing demand for integrated, high-throughput laboratory solutions.
- In October 2024, Beckman Coulter introduced the DxC 700 AU clinical chemistry analyzer with advanced reagent management and improved data connectivity features across European laboratories, indicating a shift towards more efficient and connected diagnostic workflows.
- In July 2024, Ortho Clinical Diagnostics expanded its VITROS XT 7600 integrated chemistry system portfolio with new assays for cardiac biomarkers and infectious disease markers, underscoring the trend towards multiparametric testing on a single platform.
- In December 2023, Abbott Laboratories upgraded its ARCHITECT c8000 clinical chemistry analyzer with enhanced throughput and cloud-based analytics capabilities in Europe, boosting remote monitoring and predictive maintenance to reduce downtime.
- In April 2023, Roche Diagnostics launched new reagent kits compatible with the cobas c 513 analyzer for liver function and lipid panel tests, supporting the increasing prevalence of chronic disease monitoring across European healthcare facilities.
